MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.coi.2026.102725

Медицинская библиотека · Current opinion in immunology · 2026

A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience.

Faraguna Martha C, Crescitelli Viola, Bonanomi Sonia, Kullmann Gaia A, Boffi Maria L, Pretese Roberta, Risca Giulia, Tedesco Lucia M, Pozzi Katia, Serafini Marta, van den Hout Johanna Mp, van der Ploeg Ans T, Balduzzi Adriana C, Gasperini Serena

СтатьяОбзорПеревод в очереди

Аннотация

We report on 13 classic infantile Pompe patients, including four cross-reactive immunological material negative (31%), treated with alglucosidase alpha (rhGAA) at Fondazione IRCCS San Gerardo, Monza, between 2003 and 2024. Median age at rhGAA initiation was 3.3 months, with nine patients (69%) starting on doses > 20 mg/kg/every other week. With a median follow-up of 6.9 years, the 5- and 10-year survival was 92%. Four patients died, and three became ventilator-dependent. Hypertrophic cardiomyopathy normalized in all patients, though electrocardiogram abnormalities persisted in 36%. Walking was achieved by 10 (77%). Ten patients received immune tolerance induction (77%, five primary, two secondary, three both), and seven received long-term sirolimus. Nine developed anti-rhGAA, of whom five (38%) had high-sustained antibody titers (HSAT). All had elevated creatine kinase at diagnosis; creatine phosphokinase normalized over time in four patients on 40 mg/kg/week since start without HSAT. This study offers real-world insight into managing classic infantile Pompe disease and compares the cohort's outcome to international experiences.

Для цитирования: Faraguna Martha C, Crescitelli Viola, Bonanomi Sonia, Kullmann Gaia A, Boffi Maria L, Pretese Roberta, Risca Giulia, Tedesco Lucia M, Pozzi Katia, Serafini Marta, van den Hout Johanna Mp, van der Ploeg Ans T, Balduzzi Adriana C, Gasperini Serena. A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience.. Current opinion in immunology. 2026. DOI: 10.1016/j.coi.2026.102725.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.